WW International NASDAQ: WW executives outlined the company's efforts to reposition its weight-manag

Raul Shah (@Raul_DSF) is very bullish on the future of GLP-1s due to accelerating demand trends gene

Kailera Therapeutics, Inc. targets the high-potential GLP-1 obesity market, leveraging a $718M IPO a

Novo Nordisk has lost its lead in the weight loss market. The company could face even more competiti

Shareholder yield can offer growing cash flows and total-return potential as Treasury yields rise, w

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Company plans to integrate telemedicine into its verified health intelligence platform and opens a t

From smaller portions and adults ordering kids meals to more protein and Mediterranean-style eating,

LLY's immunology portfolio is gaining ground, with steady revenue growth, pipeline expansion and acq

Heineken's US chief executive Maggie Timoney went on Bloomberg this week to explain why Serena Willi

MannKind Corporation (NASDAQ:MNKD) shares are trading lower on Wednesday as traders react to the com

SAN FRANCISCO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, be

CAPL and GLP bring distinct strengths in income, scale, leverage and valuation, setting up a closer

ACCG-2671 (oral small molecule amylin receptor agonist) demonstrated a ~6-day half-life, no serious

Generating stronger distributable cash flow in their latest quarters, these high-yield energy stocks

Global Partners (GLP) could produce exceptional returns because of its solid growth attributes.

Eli Lilly and Company TodayLLYEli Lilly and Company$1,171.40 +11.40 (+0.98%) As of 11:00 AM Eastern

Citi has reiterated its 'sell' rating on Novo Nordisk (NYSE:NVO), the Danish pharmaceutical group, w

The U.S. Food and Drug Administration (FDA) on Tuesday warned patients and healthcare providers abou

Fractyl Health NASDAQ: GUTS outlined a commercial strategy for its investigational Revita procedure,

Employer coverage of GLP-1 drugs is collapsing heading into 2027, but the FDA just gave Eli Lilly a

Global Partners (NYSE:GLP) reported quarterly earnings of $1.86 per share which beat the analyst con

Global Partners (NYSE:GLP) reported quarterly earnings of $1.85 per share which beat the analyst con

Stifel analyst Selman Akyol maintains Global Partners (NYSE:GLP) with a Hold and raises the price

Market sentiment declines, Nasdaq falls 1%. Nvidia down 5%, Salesforce up 4% in earnings. Initial jo

U.S. stock futures lower, Carter's and Dell report earnings, Global Partners and Block announce

Stifel analyst Selman Akyol maintains Global Partners (NYSE:GLP) with a Hold and lowers the price

Global Partners (NYSE:GLP) reported quarterly earnings of $0.66 per share which missed the analyst c

Global Partners (NYSE:GLP) reported quarterly earnings of $0.55 per share which missed the analyst c

Global Partners LP (NYSE:GLP) ("Global") today announced that it has priced an upsized priva

Global Partners LP (NYSE:GLP) ("Global") today announced that it intends to commence a priva

Global Partners LP (NYSE:GLP) announces with deep sadness the passing of Richard Slifka, Chairman of

U.S. stocks rallied Thursday after the Trump administration signed its first major trade agreement w

Global Partners (NYSE:GLP) reported quarterly earnings of $0.36 per share which beat the analyst con

Stifel analyst Selman Akyol downgrades Global Partners (NYSE:GLP) from Buy to Hold and raises the

Global Partners (NYSE:GLP) reported quarterly earnings of $0.52 per share which beat the analyst con

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a